Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.040
-0.020 (-0.97%)
At close: Sep 5, 2025, 4:00 PM
2.080
+0.040 (1.96%)
After-hours: Sep 5, 2025, 7:01 PM EDT

Phio Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
-7.09-7.15-10.83-11.48-13.29-8.79
Upgrade
Depreciation & Amortization
-0.040.180.190.190.07
Upgrade
Loss (Gain) From Sale of Assets
-0.01-0.01----
Upgrade
Asset Writedown & Restructuring Costs
--0.13---
Upgrade
Stock-Based Compensation
0.190.150.30.410.480.14
Upgrade
Other Operating Activities
-----0.230.11
Upgrade
Change in Accounts Payable
-0.1-0.4-0.120.5-0.45-0.08
Upgrade
Change in Other Net Operating Assets
-0.140.27-0.41-1.751.44-0.25
Upgrade
Operating Cash Flow
-7.14-7.11-10.75-12.13-11.86-8.8
Upgrade
Capital Expenditures
-0.01-0-0.01-0.12-0.05-0.02
Upgrade
Sale of Property, Plant & Equipment
0.010.01----
Upgrade
Investing Cash Flow
00.01-0.01-0.12-0.05-0.02
Upgrade
Long-Term Debt Issued
-----0.23
Upgrade
Long-Term Debt Repaid
------0.03
Upgrade
Net Debt Issued (Repaid)
-----0.2
Upgrade
Issuance of Common Stock
13.2247.45-21.7215.94
Upgrade
Repurchase of Common Stock
-0-0.01-0.04-0.03-0-0.02
Upgrade
Financing Cash Flow
13.2147.41-0.0321.7216.13
Upgrade
Net Cash Flow
6.08-3.11-3.34-12.289.817.31
Upgrade
Free Cash Flow
-7.15-7.11-10.75-12.25-11.91-8.82
Upgrade
Free Cash Flow Per Share
-2.54-9.03-46.45-97.00-100.24-207.68
Upgrade
Cash Interest Paid
0.010.010.01--0.01
Upgrade
Levered Free Cash Flow
-4.71-4.54-6.58-7.81-6.71-5.55
Upgrade
Unlevered Free Cash Flow
-4.71-4.54-6.58-7.81-6.71-5.55
Upgrade
Change in Working Capital
-0.24-0.14-0.54-1.260.99-0.33
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q